NUCALA should not be administered to patients with a history of hypersensitivity to mepolizumab or excipients in the formulation.


In addition to a patient profile, this presentation includes a review of the SIRIUS study. The SIRIUS study was one of the confirmatory clinical trials that evaluated the effect of NUCALA on oral corticosteroid dose in patients with severe asthma with an eosinophilic phenotype.

825656R0 September 2017